These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 4144474)

  • 1. Progress in the prevention of GVH: bone marrow grafts after ALG conditioning, with lymphocyte split chimerism, use of a lymphocyte "chalone T", and soluble histocompatibility antigens.
    Mathé G; Kiger N; Florentin I; Garcia-Giralt E; Martyre MC; Halle-Pannenko O; Schwartzenberg L
    Transplant Proc; 1973 Mar; 5(1):933-9. PubMed ID: 4144474
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevention of graft-versus-host disease by Fab fragments derived from ALG.
    Richie ER; Gallagher MT; Trentin JJ
    Transplant Proc; 1973 Mar; 5(1):873-6. PubMed ID: 4144467
    [No Abstract]   [Full Text] [Related]  

  • 3. Adaptive phenomena in bone marrow transplantation.
    Goujet-Zalc C; Ilbery PL
    Exp Hematol; 1973; 1(1):3-10. PubMed ID: 4154047
    [No Abstract]   [Full Text] [Related]  

  • 4. Regulation and suppression of graft-versus-host reaction.
    Nouza K; Pichlílová
    Allerg Immunol (Leipz); 1973; 19(2-4):279-89. PubMed ID: 4156162
    [No Abstract]   [Full Text] [Related]  

  • 5. Thymus dependence of lymphocyte trapping.
    Zatz MM; Gershon RK
    J Immunol; 1974 Jan; 112(1):101-6. PubMed ID: 4149589
    [No Abstract]   [Full Text] [Related]  

  • 6. Bone marrow transplantation after antilymphocyte globulin conditioning--split lymphocyte chimerism.
    Mathé G; Schwarzenberg L; Amiel JL; Schneider M; Belpomme D; Jasmin C; Rosenfeld C; Hayat M; de Vassal F; Steresco M
    Transplant Proc; 1972 Dec; 4(4):551-7. PubMed ID: 4566797
    [No Abstract]   [Full Text] [Related]  

  • 7. Of mice and men in bone marrow transplantation.
    Mathé G; Schwarzenberg L; Halle-Pannenko O; Abuaf N; Pouillart P
    Transplant Proc; 1977 Mar; 9(1):155-68. PubMed ID: 17189
    [No Abstract]   [Full Text] [Related]  

  • 8. Bone marrow transplantation in rats across strong histocompatibility barriers by selective elimination of lymphoid cells in donor marrow.
    Müller-Ruchholtz W; Wottge HU; Müller-Hermelink HK
    Transplant Proc; 1976 Dec; 8(4):537-41. PubMed ID: 11584
    [No Abstract]   [Full Text] [Related]  

  • 9. Durable mixed allogeneic chimerism and tolerance by a nonlethal radiation-based cytoreductive approach.
    Colson YL; Li H; Boggs SS; Patrene KD; Johnson PC; Ildstad ST
    J Immunol; 1996 Oct; 157(7):2820-9. PubMed ID: 8816385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of graft-versus-host-reaction (GVHR) by in vitro incubation of donor lymphocytes with thymic or splenic chalone (s).
    Kiger N; Florentin I; Garcia-Giralt E; Mathé G
    Exp Hematol; 1973; 1(1):22-8. PubMed ID: 4153630
    [No Abstract]   [Full Text] [Related]  

  • 11. Soluble H-2 antigens: effect on graft-versus-host reaction and factors influencing its effect on host-versus-skin-graft reaction.
    Halle-Pannenko O; Martyre MC; Mathé G
    Transplant Proc; 1972 Dec; 4(4):517-21. PubMed ID: 4405145
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of restoring lethally irradiated mice with anti-Thy 1.2-treated bone marrow: graft-vs-host, host-vs-graft, and mitogen reactivity.
    Norin AJ; Emeson EE
    J Immunol; 1978 Mar; 120(3):754-8. PubMed ID: 24664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Suppression of antibody formation by bone marrow T-cells activated by histocompatibility antigens].
    Gambarov SS; Khaitov RM
    Biull Eksp Biol Med; 1977 Mar; 83(3):300-2. PubMed ID: 322761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The double barrier in bone marrow transplantation.
    van Bekkum DW
    Semin Hematol; 1974 Jul; 11(3):325-40. PubMed ID: 4151846
    [No Abstract]   [Full Text] [Related]  

  • 15. Human marrow transplantation--current status.
    Buckner CD; Clift RA; Fefer A; Neiman P; Storb R; Thomas ED
    Prog Hematol; 1973; 8():299-324. PubMed ID: 4150971
    [No Abstract]   [Full Text] [Related]  

  • 16. Rationale for the use of ALG as sole immunosuppressant in allogeneic bone marrow transplantation for aplastic anemia.
    Speck B; Buckner CD; Cornu P; Jeannet B
    Transplant Proc; 1976 Dec; 8(4):617-22. PubMed ID: 11593
    [No Abstract]   [Full Text] [Related]  

  • 17. Reconstitution ratio is critical for alloreactive T cell deletion and skin graft survival in mixed bone marrow chimeras.
    Taniguchi H; Abe M; Shirai T; Fukao K; Nakauchi H
    J Immunol; 1995 Dec; 155(12):5631-6. PubMed ID: 7499847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antilymphocytic antibodies and marrow transplantation. V. Suppression of secondary disease by host-versus-theta-graft reaction.
    Thierfelder S; Rodt H
    Transplantation; 1977 Jan; 23(1):87-92. PubMed ID: 319574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Photochemical treatment with S-59 psoralen and ultraviolet A light to control the fate of naive or primed T lymphocytes in vivo after allogeneic bone marrow transplantation.
    Truitt RL; Johnson BD; Hanke C; Talib S; Hearst JE
    J Immunol; 1999 Nov; 163(9):5145-56. PubMed ID: 10528221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of prior blood transfusions on marrow grafts: abrogation of sensitization by procarbazine and antithymocyte serum.
    Storb R; Floersheim GL; Weiden PL; Graham TC; Kolb HJ; Lerner KG; Schroeder ML; Thomas ED
    J Immunol; 1974 Apr; 112(4):1508-16. PubMed ID: 4592604
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.